I think it’s 50/50 at this point and could go either way. There’s a lot of good points made on both sides, whether you’re positive or negative on this company at this point. Which is pretty unsettling after 3 years of being certain these guys had something special, at least with Clone 3. I keep thinking the same thing everyone has been saying, that if these guys really had the goods, why has no one bought them out or partnered and why are they left going the route of some amateur hour spac company and Bulgarian clinicals?! Two years from the Samsung PR, have to think that was nothing more than a glorified agreement for ENZC to pay them to produce mabs. Well over a year since the NDA talk. Still nothing. Personally clinging to my last hope that we get surprise news that the breakthrough Regeneron Covid mab is us after all. Otherwise, losing all hope here fast. This spac deal is feeling worse and worse the further we get. I don’t want to sit for 6 months with locked dividend shares and stomach watching $10 SAGA shares trickle down to $1 or under as they add / dilute shares to the o/s or something else. And I’m talking post dividend, not during the make whole window. The second this dividend is complete, unless they are in at least one major clinical trial showing promising results or some other major partnership is announced, it’s not going to hold. People may scoff at that, but I’ve personally witnessed another small bio, already on NASDAQ and already in a stage 2 clinical trial bleed from over $10 last year around this time to under .50 cents now. On no bad news, and with continued progress. Yep, you read that right. They would need massive news to hold that $10 SAGA price after all the new shares are added. Not to mention our dividend shares now become short term as well. Then we may be sitting with months of locked shares we can’t sell while company execs can and will dump some of theirs. That’s why I hope something big drops before this whole dividend thing plays out. But with their track record, I doubt it.
